arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

OneMedNet Corp

ONMD

$0.65 ▼ -0.01 (-1.98%) at close

23 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Moderately Bullish

auto_awesome

Analytical Summary

OneMedNet Corp shows strong fundamentals with top-quartile Return on Common Equity (%) and Debt to Equity. Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap $37.7M

Dividend Yield —

Revenue Growth 88.4% ↗

Op. Margin None

ROIC 52.8% ↗

FCF / Share $-0.03 ↘

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity -0.04

info Valuation on last close. End-of-day price, Sep 23, 2026.

23-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$292.00K

↑ +88.4% —

Net Income Profit after all expenses

$-2.45M

↓ -29.0% —

FCF / Share Free cash flow per share

$-0.03

↓ -16.3% —

Long-Term Debt Long-term obligations

$132.00K

↓ -25.0% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability

Returns

Financial Health ↓

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Feb 7, 2021 10-K ↗
Revenue Growth YoY (%)	88.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1668%)	-29.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-699%)	3326.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+66438%)	24.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+393%)	-31.7% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-734%)	-44.8% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-995%)	-92.4% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1947%)	-56.4% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1229%)	—	—	28.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+478%)	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	N/M	33.3% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	85.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	33.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	97.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-29.0% Weak ↓ Weak Declining Year-over-year change in net income	-29.0% Weak ↓ Weak Declining Year-over-year change in net income	-32.3% Weak ↓ Weak Declining Year-over-year change in net income	9.8% Fair ↑ Fair Improving Year-over-year change in net income	9.8% Fair ↓ Fair Declining Year-over-year change in net income	9.8% Fair ↑ Fair Improving Year-over-year change in net income	4.9% Caution ↑ Caution Improving Year-over-year change in net income	73.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-2352.8% Weak ↓ Weak Declining Year-over-year change in net income	-2352.8% Weak ↓ Weak Declining Year-over-year change in net income	-14.9% Weak Weak Year-over-year change in net income	-8.9% Weak Weak Year-over-year change in net income	N/M	N/M	N/M	-852267.5% Weak Weak Year-over-year change in net income	-49.0% Weak Weak Year-over-year change in net income	N/M	—	—	—	—	—
FCF Growth YoY (%)	—	51.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	12.7% Fair Fair Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	50.0% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Feb 7, 2021 10-K ↗
Operating Margin (%) (%)	—	—	-345.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2983%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	109.0% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	-225.9% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	-352.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4505%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	-192.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	-343.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.77x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.63x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.55x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	—	1.03x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.74x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.70x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.14x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.61x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-42.09x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.52x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	—	-0.13x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-0.10x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.00x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Feb 7, 2021 10-K ↗
Return on Invested Capital (%)	52.8% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	51.7% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	88.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	44.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	42.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	12.4% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	13.5% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	15.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	11.5% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	10.6% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	11.4% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	3.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-0.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	12.2% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	-65.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	—	9.5% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	7.5% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	3.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	1.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-1.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-165.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-169.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-143.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-148.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-88.3% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-128.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-72.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-54.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-235.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-280.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-402.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-1.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-1.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-25.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-0.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-0.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-0.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-0.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-0.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	69.7% Excellent → Excellent Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+365%)	60.1% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+301%)	105.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+606%)	48.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+222%)	49.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+230%)	11.5% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-23%)	14.9% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	14.8% Fair → Fair Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	11.0% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-27%)	13.4% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-10%)	18.6% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+24%)	16.4% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+9%)	0.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-94%)	0.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-94%)	-23.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-256%)	—	-33.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-321%)	-34.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-328%)	-9.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-164%)	0.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-100%)	86.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+474%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Feb 7, 2021 10-K ↗
Debt to Equity (x)	-0.04x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-105%)	-0.04x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-106%)	-0.07x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-111%)	—	—	-0.28x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-140%)	—	-0.32x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-146%)	-0.12x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-118%)	—	-0.07x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-110%)	—	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	-251.22x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-255.20x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-308.20x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-89.40x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-444.80x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-170.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-163.60x Weak Weak Operating income divided by interest expense Optimal: > 5x	-84.04x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	-58.73x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—
Net Debt (USD)	$-226.00K	$-57.00K	$-365.00K	$-149.00K	$-122.00K	$4.52M	$-172.00K	$2.68M	$1.99M	$-174.00K	$883.00K	—	$-3.44K	$-10.11K	$-301.73K	—	$-7.48K	$-159.13K	$-453.15K	$-533.71K	$-802.11K	—	—
Debt / EBITDA (x)	-0.06x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.07x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.07x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	-2.11x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-1.93x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.97x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-0.50x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Feb 7, 2021 10-K ↗
Revenue per Share (USD)	$0.01	$0.00	—	$0.00	$0.00	$0.00	—	$0.01	$0.01	$0.01	—	$0.08	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.04	$-0.04	$-0.07	$-0.01	$0.07	$-0.06	$-0.07	$-0.07	$-0.15	$-0.09	$2.91	$-3.23	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.03	$-0.03	—	$-0.03	—	$-0.06	—	—	—	$-0.07	—	$-0.26	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$-0.06	$-0.08	$-0.06	$-0.08	$-0.08	$-0.54	$-0.57	$-0.51	$-0.80	$-0.66	$-0.57	$-11.17	—	—	$2.04	—	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$-0.06	$-0.08	$-0.06	$-0.08	$-0.08	$-0.54	$-0.57	$-0.51	$-0.80	$-0.66	$-0.57	$-11.17	—	—	$2.04	—	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	58.02M	55.32M	—	52.62M	36.84M	34.10M	—	27.88M	23.94M	23.68M	—	4.28M	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Feb 7, 2021 10-K ↗
Working Capital (USD)	$-3.41M	$-3.90M	$-2.73M	$-3.56M	$-3.89M	$-16.52M	$-15.61M	$-14.32M	$-19.09M	$-14.00M	$-13.47M	—	$-2.09M	$-2.33M	$18.57M	—	$-1.16M	$-363.95K	$246.23K	$661.57K	$760.30K	—	—
LT Debt (USD)	$132.00K	$176.00K	$220.00K	—	—	$2.33M	—	$2.31M	$2.39M	—	$465.00K	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$-3.52M	$-4.08M	$-2.96M	$-3.94M	$-3.84M	$-16.55M	$-15.95M	$-14.27M	$-19.19M	$-15.70M	$-13.44M	$-47.80M	$-10.09M	$-9.48M	$9.27M	—	$-6.61M	$-6.41M	$-8.61M	$-8.14M	$5.00M	$0.00	$0.00

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Dec 31, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Feb 7, 2021 10-K ↗
Sales/Revenue/Turnover (USD)	$292.00K	$96.00K	$891.00K	$177.00K	$155.00K	$137.00K	$26.00K	$142.00K	$227.00K	$248.00K	$340.00K	$326.00K	—	—	$263.77K	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	—	$11.00K	$9.00K	$10.00K	$34.00K	$12.00K	$26.00K	—	—	$11.00K	$9.00K	$6.00K	—	—	$8.55K	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-2.45M	$-2.45M	$-3.14M	$-1.90M	$-1.90M	$-1.90M	$-2.37M	$-2.11M	$-2.11M	$-2.11M	$-2.50M	$-7.84M	$-85.98K	$-85.98K	$-2.17M	$-7.20M	$2.20M	$2.20M	$828.48K	$-845.00	$4.31M	$-845.00	—
Operating Cash Flow (USD)	$-1.88M	$-1.54M	$-1.71M	$-1.75M	—	$-1.95M	$-2.00M	—	—	$-1.55M	$-1.73M	$-1.10M	—	$-52.46K	$91.45M	$-3.76M	—	$-294.02K	$-80.56K	—	—	$0.00	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 6 years · 23 quarters

OneMedNet Corp

Analytical Summary

23-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ONMD with peers